Figure 3. Western blot validation of four candidate cholangiocarcinoma biomarkers in individual bile samples.
Western blotting (top) and quantification (bottom) of candidate biomarker expression in equal volumes of individual bile samples from 10 cholangitis patients (benign) and 19 cholangiocarcinoma (CC) patients. (A) PGAM-1; (B) PDIA3; (C) HSPD1 (D) and SSP411.